MYC has ubiquitous cellular functions and has been characterised as a pro‐leukaemogenic oncogene in AML; for example, it may drive drug resistance [31, 32] and its expression can be prognostic for patient outcome [33]. Here, MYC is linked to acute myeloid leukemia.